TCR Affinity and Tolerance Mechanisms Converge To Shape T Cell Diabetogenic Potential

Autoreactive T cells infiltrating the target organ can possess a broad TCR affinity range. However, the extent to which such biophysical parameters contribute to T cell pathogenic potential remains unclear. In this study, we selected eight InsB9–23-specific TCRs cloned from CD4+ islet-infiltrating T cells that possessed a relatively broad range of TCR affinity to generate NOD TCR retrogenic mice. These TCRs exhibited a range of two-dimensional affinities (∼10−4–10−3 μm4) that correlated with functional readouts and responsiveness to activation in vivo. Surprisingly, both higher and lower affinity TCRs could mediate potent insulitis and autoimmune diabetes, suggesting that TCR affinity does not exclusively dictate or correlate with diabetogenic potential. Both central and peripheral tolerance mechanisms selectively impinge on the diabetogenic potential of high-affinity TCRs, mitigating their pathogenicity. Thus, TCR affinity and multiple tolerance mechanisms converge to shape and broaden the diabetogenic T cell repertoire, potentially complicating efforts to induce broad, long-term tolerance.

[1]  M. Nakayama,et al.  Generation of T cell receptor–retrogenic mice: improved retroviral-mediated stem cell gene transfer , 2013, Nature Protocols.

[2]  B. Evavold,et al.  Monitoring the Dynamics of T Cell Clonal Diversity Using Recombinant Peptide:MHC Technology , 2013, Front. Immunol..

[3]  Ronald N Germain,et al.  T cell-positive selection uses self-ligand binding strength to optimize repertoire recognition of foreign antigens. , 2013, Immunity.

[4]  D. Vignali,et al.  Prevention of Autoimmune Diabetes by Ectopic Pancreatic β-Cell Expression of Interleukin-35 , 2012, Diabetes.

[5]  M. Croft,et al.  Following the Fate of One Insulin-Reactive CD4 T cell , 2012, Diabetes.

[6]  B. Evavold,et al.  Low 2-Dimensional CD4 T Cell Receptor Affinity for Myelin Sets in Motion Delayed Response Kinetics , 2012, PloS one.

[7]  Susana Gordo,et al.  Self-reactive human CD4 T cell clones form unusual immunological synapses , 2012, The Journal of experimental medicine.

[8]  K. Garcia,et al.  T cell receptor signaling is limited by docking geometry to peptide-major histocompatibility complex. , 2011, Immunity.

[9]  E. Unanue,et al.  Register shifting of an insulin peptide–MHC complex allows diabetogenic T cells to escape thymic deletion , 2011, The Journal of experimental medicine.

[10]  P. Marrack,et al.  Specificity and detection of insulin-reactive CD4+ T cells in type 1 diabetes in the nonobese diabetic (NOD) mouse , 2011, Proceedings of the National Academy of Sciences.

[11]  Nicole R. Cunningham,et al.  T cell receptor signal strength in Treg and iNKT cell development demonstrated by a novel fluorescent reporter mouse , 2011, The Journal of experimental medicine.

[12]  B. Evavold,et al.  High prevalence of low affinity peptide–MHC II tetramer–negative effectors during polyclonal CD4+ T cell responses , 2011, The Journal of experimental medicine.

[13]  J. Allison,et al.  TCR ligand density and affinity determine peripheral induction of Foxp3 in vivo , 2010, The Journal of experimental medicine.

[14]  P. Marrack,et al.  Diabetogenic T cells recognize insulin bound to IAg7 in an unexpected, weakly binding register , 2010, Proceedings of the National Academy of Sciences.

[15]  E. Unanue,et al.  In Autoimmune Diabetes Unique Autoreactive T Cells Recognize Insulin Peptides Generated in the Islets of Langerhans , 2010, Nature Immunology.

[16]  Cheng Zhu,et al.  The kinetics of two dimensional TCR and pMHC interactions determine T cell responsiveness , 2010, Nature.

[17]  C. Benoist,et al.  How punctual ablation of regulatory T cells unleashes an autoimmune lesion within the pancreatic islets. , 2009, Immunity.

[18]  D. Vignali,et al.  T cell islet accumulation in type 1 diabetes is a tightly regulated, cell-autonomous event. , 2009, Immunity.

[19]  V. Gersuk,et al.  Changes in autoreactive T cell avidity during type 1 diabetes development. , 2009, Clinical immunology.

[20]  C. Benoist,et al.  Foxp3+ regulatory T cells: differentiation, specification, subphenotypes , 2009, Nature Immunology.

[21]  E. Palmer,et al.  Affinity threshold for thymic selection through a T-cell receptor–co-receptor zipper , 2009, Nature Reviews Immunology.

[22]  R. Tisch,et al.  On the Pathogenicity of Autoantigen-Specific T-Cell Receptors , 2008, Diabetes.

[23]  Cheng Zhu,et al.  Kinetics of MHC-CD8 Interaction at the T Cell Membrane1 , 2007, Journal of Immunology.

[24]  Andrew K. Sewell,et al.  Human TCR-Binding Affinity is Governed by MHC Class Restriction1 , 2007, The Journal of Immunology.

[25]  J. Holst,et al.  Rapid analysis of T-cell selection in vivo using T cell–receptor retrogenic mice , 2006, Nature Methods.

[26]  D. Hafler,et al.  Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope , 2005, Nature.

[27]  C. Hausl,et al.  Clonal selection of helper T cells is determined by an affinity threshold with no further skewing of TCR binding properties. , 2004, Immunity.

[28]  D. Moskophidis,et al.  TCR affinity and negative regulation limit autoimmunity , 2004, Nature Medicine.

[29]  D. Vignali,et al.  Diabetes Incidence Is Unaltered in Glutamate Decarboxylase 65-Specific TCR Retrogenic Nonobese Diabetic Mice: Generation by Retroviral-Mediated Stem Cell Gene Transfer1 , 2004, The Journal of Immunology.

[30]  K. Garcia,et al.  Peptide register shifting within the MHC groove: theory becomes reality. , 2004, Molecular immunology.

[31]  Simon J Davis,et al.  Molecular interactions mediating T cell antigen recognition. , 2003, Annual review of immunology.

[32]  G. Eisenbarth,et al.  Evidence for a primary islet autoantigen (preproinsulin 1) for insulitis and diabetes in the nonobese diabetic mouse , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[33]  C. Boitard,et al.  Acceleration of type 1 diabetes mellitus in proinsulin 2-deficient NOD mice. , 2003, The Journal of clinical investigation.

[34]  M. Purbhoo,et al.  Sensory Adaptation in Naive Peripheral CD4 T Cells , 2001, The Journal of experimental medicine.

[35]  E. Leiter The NOD Mouse: A Model for Insulin‐Dependent Diabetes Mellitus , 1997, Current protocols in immunology.

[36]  S. Tafuro,et al.  Progression of autoimmune diabetes driven by avidity maturation of a T-cell population , 2000, Nature.

[37]  P. Allen,et al.  A Kinetic Threshold between Negative and Positive Selection Based on the Longevity of the T Cell Receptor–Ligand Complex , 1999, The Journal of experimental medicine.

[38]  S. Kanner,et al.  CD5 Negatively Regulates the T-Cell Antigen Receptor Signal Transduction Pathway: Involvement of SH2-Containing Phosphotyrosine Phosphatase SHP-1 , 1999, Molecular and Cellular Biology.

[39]  A. Grinberg,et al.  CD5 Expression Is Developmentally Regulated By T Cell Receptor (TCR) Signals and TCR Avidity , 1998, The Journal of experimental medicine.

[40]  Z Reich,et al.  Ligand recognition by alpha beta T cell receptors. , 1998, Annual review of immunology.